# Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food

> **NCT02143856** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 100 mg GLPG1205

## Key facts

- **NCT ID:** NCT02143856
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02143856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02143856, "Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02143856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*